ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer	Metastatic Castration-Resistant Prostate Cancer	Recruiting	Phase 2	2026-05-08		NCT04986423

3 results · Page 1 of 1

Swipe the table sideways for more columns.

31 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Anhui Provincial Hospital	Hefei	China	7
BRCR Global	Plantation	United States	12
California Research Institute	Los Angeles	United States	15
Chongqing Cancer Hospital	Chongqing	China	16
Colorado Urology	Lakewood	United States	3
D&H Cancer Research Center, LLC	Margate	United States	1
First Hospital of Shanxi Medical University	Taiyuan	China	16
Fudan University Shanghai Cancer Center	Shanghai	China	257
Hematology Oncology Clinic	Baton Rouge	United States	4
Henan Cancer Hospital	Zhengzhou	China	76
Hubei Cancer Hospital	Wuhan	China	95
Hunan Cancer Hospital	Changsha	China	6
Innovative Clinical Research Institute	Whittier	United States	4
Liaoning Cancer Hospital	Shenyang	China	15
Maryland Oncology Hematology, P.A.	Columbia	United States	9
Messino Cancer Center	Asheville	United States	7
Nanjing Drum Tower Hospital	Nanjing	China	52
Northwest Cancer Specialists, P.C.	Portland	United States	1
Seattle Cancer Care Alliance	Seattle	United States	36
Shanghai Tenth People's Hospital	Shanghai	China	22
Sichuan Provincial People's Hospital	Chengdu	China	50
Texas Oncology - Central South	Austin	United States	8
The First Affiliated Hospital of Xi'an Jiaotang University	Xi'an	China	1
The First Affiliated hospital of Xiamen University	Xiamen	China	69
Tongji Hospital of Tongji Medical College, Huazhong University of Science & Technology	Wuhan	China	1

Clinical trials